mCSPC Education: Symptom Management During Treatment of mCSPC

Interested in Discount Institutional Group Pricing? Learn more about ONS ON-Demand™ or email


Androgen deprivation therapy (ADT) treatment of metastatic castration-sensitive prostate cancer (mCSPC) can lead to a variety of side effects that may be uncomfortable for patients. In this interactive case study, learners will be introduced to some common side effects of ADT and review management strategies.

This resource was developed by ONS through an educational grant from Astellas and Pfizer Inc. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.

You will enjoy access for 90 days from date of purchase, after which you will no longer be able to access the course.

To receive nursing continuing professional development (NCPD) contact hours, the following requirements must be met prior to the closing date and time of the course: 

  • Achieve 80% or higher on the post‐test. (Note: You will have two [2] attempts to achieve a score of 80% or higher on the post-test.)
  • Completion of the course evaluation. A course evaluation MUST be completed to be granted the NCPD contact hours. The evaluation link is locked until passing the post-test.

Course Topics

  • Prostate cancer
  • Symptom management

Expected Outcomes

  • Learners will report an increase in knowledge related to care of patients receiving treatment for mCSPC. 
  • Learners will report an increase in confidence in managing side effects of mCSPC treatment.

Target Audience

Oncology nurses and other care providers, including point-of-care, care coordinators, and nurse navigators.

ILNA Breakdown

Up to .75 ILNA points may be applied to Coordination of Care OR Oncology Nursing Practice OR Symptom Management OR Treatment.  No more than .75 total points may be claimed for the program.

ONS Courses

Earn valuable NCPD, and stay on the forefront of oncology nursing.

View All Courses